Document Type
Article
Publication Date
4-26-2016
Abstract
BMAL1 and RORα are major regulators of the circadian molecular oscillator. Since previous work in other cell types has shown cross talk between circadian rhythm genes and hypoxic signaling, we investigated the role of BMAL1 and RORα in controlling HIF-1-dependent transcriptional responses in NP cells that exist in the physiologically hypoxic intervertebral disc. HIF-1-dependent HRE reporter activity was further promoted by co-transfection with either BMAL1 or RORα. In addition, stable silencing of BMAL1 or inhibition of RORα activity resulted in decreased HRE activation. Inhibition of RORα also modulated HIF1α-TAD activity. Interestingly, immunoprecipitation studies showed no evidence of BMAL1, CLOCK or RORα binding to HIF-1α in NP cells. Noteworthy, stable silencing of BMAL1 as well as inhibition of RORα decreased expression of select HIF-1 target genes including VEGF, PFKFB3 and Eno1. To delineate if BMAL1 plays a role in maintenance of disc health, we studied the spinal phenotype of BMAL1-null mice. The lumbar discs of null mice evidenced decreased height, and several parameters associated with vertebral trabecular bone quality were also affected in nulls. In addition, null animals showed a higher ratio of cells to matrix in NP tissue and hyperplasia of the annulus fibrosus. Taken together, our results indicate that BMAL1 and RORα form a regulatory loop in the NP and control HIF-1 activity without direct interaction. Importantly, activities of these circadian rhythm molecules may play a role in the adaptation of NP cells to their unique niche.
Recommended Citation
Suyama, Kaori; Silagi, Elizabeth S; Choi, Hyowon; Sakabe, Kou; Mochida, Joji; Shapiro, Irving M; and Risbud, Makarand V, "Circadian factors BMAL1 and RORα control HIF-1α transcriptional activity in nucleus pulposus cells: implications in maintenance of intervertebral disc health." (2016). Department of Orthopaedic Surgery Faculty Papers. Paper 85.
https://jdc.jefferson.edu/orthofp/85
Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.
PubMed ID
27049729
Comments
This article has been peer reviewed. It was published in: Oncotarget.
Volume 7, Issue 17, 26 April 2016, Pages 23056-23071.
The published version is available at DOI: 10.18632/oncotarget.8521
Copyright © 2016 The Authors